The difference between groups was not significant over extended ... occurred after the patients had crossed over to receive either a transvenous ICD or cardiac resynchronization therapy-defibrillator ...

However, there were no differences in cardiovascular hospitalization or mortality between groups. Both trials “showed that catheter ablation soon after ICD implant or after an ICD shock reduced ...

Compared with medical management, ablation was associated with lower rates of recurrent ventricular arrhythmias, implantable cardioverter-defibrillator (ICD) shocks ... There was no difference between ...

Learn to distinguish life-threatening heart attack signs from less serious causes of chest pain, and discover when you should ...

Rates of arrhythmic events and death remained common in patients indicated for implantable cardioverter defibrillator or ...

Relatively weak magnets in consumer products have always posed some risk, usually very low, to the function of pacemakers and implantable cardioverter-defibrillators (ICDs). However, stronger ...

Background: The PRAETORIAN trial investigated the efficacy and safety of the subcutaneous implantable cardioverter-defibrillator (S-ICD ... demonstrated that there was no significant difference ...

Mitchell van der Gaag reflects on his terrifying cardiac arrest, inspiring tattoos, and his unwavering ambition to return as ...

Studies evaluated the company’s implantable cardioverter defibrillators ... difference in complications after 87.5 months. However, the ATA showed significantly more complications in the TV-ICD ...